Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ecovelex 2026 Approval in Italy

17th Nov 2026 07:00

RNS Number : 3922D
Eden Biosolutions PLC
17 November 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

​

Eden BioSolutions plc

("Eden" or the "Company")

 

Ecovelex 2026 Approval in Italy

Fourth consecutive emergency authorisation, covering the 2027 maize season

 

Eden BioSolutions plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that Ecovelex™ 2026 has been granted a 120-day temporary authorisation in Italy for use as a bird-repellent seed treatment on maize in the 2027 growing season.

 

This is the fourth consecutive year that Ecovelex has received temporary authorisation in Italy and covers industrial seed treatment of maize for grain, forage, silage and sweet corn, protecting against multiple bird species.

 

The repeated grants reflect continued grower demand for a biological alternative to conventional bird-repellent seed treatments, which are expected to be withdrawn within the next two years. In Italy, temporary use has previously led to full authorisation of Eden products: Cedroz™ received emergency authorisations in 2019 and 2020 ahead of full authorisation in May 2021.

 

Meanwhile, the EU-wide authorisation of Ecovelex is progressing well with recent entry into one of the final review stages.  Austria is acting as rapporteur Member State, and once approved at EU level, each Member State must ratify it before granting local authorisation.

 

Corteva Agriscience (Corteva) and Eden BioSolutions are collaborating on Ecovelex, combining Corteva's seed-applied technology expertise with Eden's plant-derived chemistry and Sustaine® microencapsulation technology, with Corteva serving as the exclusive distribution partner.

Sean Smith, CEO of Eden, commented:

 

"A fourth consecutive temporary authorisation shows the value that Italian maize growers and regulators place on Ecovelex™, now an established tool for protecting maize seed from bird damage in one of Europe's most important agricultural markets. We will continue to work closely with Corteva on preparations for product launch while the EU review progresses towards full authorisation as we focus on expanding the availability of Ecovelex™ across Europe and enhancing commercial development opportunities."

 

For further information contact:

 

Eden BioSolutions plc

www.edenresearch.com

Sean Smith, Chief Executive Officer

Via Walbrook PR

Alex Abrey, Chief Financial Officer

 

 

 

Cavendish Capital Markets Limited (Nominated advisor and joint broker)

Tel: 020 7220 0500

Giles Balleny / Elysia Bough (Corporate Finance)

 

Harriet Ward (Corporate Broking) / Dale Bellis (Sales)

 

 

 

Oberon Capital (Joint Broker)

Tel: 020 3179 5300

Mike Seabrook / Aimee McCusker

 

 

 

Walbrook PR (Media Relations & Investor Relations)

Tel: 020 7933 8780 or [email protected]

Paul McManus / Nick Rome

/ Anna Dunphy

Mob: +44 7980 541 893 / Mob: +44 7748 325 236

/ Mob: +44 7876 741 001

 

 

 

Notes to Editors:

 

Eden BioSolutions is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which targets fungal diseases, such as Botrytis cinerea, powdery mildew, and downy mildew, affecting high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally. Mevalone Delta is a new, enhanced version of Mevalone®.

 

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

 

Eden's seed treatment product, Ecovelex was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, US and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

 

Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which the Company still holds to date. The Green Economy Mark recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

 

For more information about Eden, please visit:  www.edenbiosolutions.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAEFKFEPKFAA

Related Shares:

Eden Research
FTSE 100 Latest
Value10,560.95
Change-128.92